Articles published by NanoVibronix, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes
January 07, 2025
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan
January 06, 2025
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement
December 11, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Provides Business Update
November 12, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany
October 09, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Signs Letter of Intent with Potential New Distributor
September 23, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
May 22, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://mms.businesswire.com/media/20240516840704/en/2132996/22/NAOV_logo.jpg)
NanoVibronix Issues Letter to Stockholders
May 16, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://mms.businesswire.com/media/20240514869740/en/2129068/22/NAOV_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Issues Letter to Stockholders
April 09, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
March 28, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://mms.businesswire.com/media/20231206453100/en/1961898/5/NAOV_PR_12-6.jpg)
NanoVibronix Featured in Your Bladder Health Magazine
December 06, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
November 28, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Regains Nasdaq Compliance
November 21, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Issues Letter to Shareholders
November 14, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
September 27, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
September 06, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 30, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Responds to CMS’ Determination for PainShield
August 29, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
August 28, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://mms.businesswire.com/media/20230823426842/en/1873378/22/NAOV_PR_Photo_2.jpg)
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
August 23, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Issues Letter to Shareholders
May 18, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Issues Letter to Shareholders
April 18, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free